Our team of seasoned SMEs (subject matter experts), immunologists, and cellular biologists possesses extensive experience in understanding the pathogenesis, immmunogenicity, and disease intervention strategies for a wide range of infectious diseases. We are proficient in a variety of in vitro and in vivo infectious disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutics.
We offer a comprehensive suite of preclinical infectious disease services—including Select Agent and BSL-3 capabilities—tailored to address the diverse challenges posed by these diseases, encompassing every stage of the research process:
Pathogen Identification, Propagation, and Characterization: We help you identify and characterize novel pathogens, providing crucial insights into their biology and potential therapeutic targets.
Antimicrobial Compound Screening and Optimization: We utilize a range of in vitro screening assays to identify promising antimicrobial candidates and optimize their potency and spectrum of activity.
Efficacy and Safety Testing in Animal Models: We conduct rigorous efficacy and safety testing in animal models to assess therapeutic potential.
Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.
Additionally, we offer assay development, animal model development, clinical trial support, and a repository of potential pandemic pathogens.
